华大智造：关于开立募集资金现金管理专用结算账户的公告

Core Points - The company, BGI Genomics, announced plans to utilize idle funds for cash management, with a maximum of RMB 20 billion from its own funds and RMB 17 billion from raised funds [2] Group 1 - The second board meeting and supervisory board meeting will be held on April 24, 2025, to review the cash management proposal [2] - The funds will be used to purchase high-security and high-liquidity deposit products or capital-protected products [2] - The approved fund usage is valid for 12 months from the date of the board's approval, allowing for rolling use of the funds within the specified limits [2]